AHA advocates for stronger health care supply chain in comments for House subcommittee hearing

Jun 11, 2025 - 03:20 PM
US Capitol with flag 900 x 400

The AHA submitted a statement today to the House Energy and Commerce Subcommittee on Health for a hearing today on the health care supply chain. The AHA advocated for strengthening the health care supply chain while acknowledging significant time would be needed due to logistical complexities and resources needed to do so. 
 
Additionally, the AHA noted that pharmaceuticals sourced from overseas are significantly important for patients, such as cancer and cardiovascular medications, immunosuppressives, antibiotics and combination antibiotics. The AHA also reiterated its support for the Mapping America’s Pharmaceutical Supply Act (S. 1784), legislation that would require the Department of Health and Human Services to perform a comprehensive risk assessment of the entire U.S. pharmaceutical supply chain. 

Related News Articles

Headline
HSCC releases guide on third-party AI risk, supply chain transparency
The Health Sector Coordinating Council’s Cybersecurity Working Group has released a guide on third-party artificial intelligence risk and AI supply…
Headline
Administration announces additional pharmaceutical tariffs
The White House April 2 issued a proclamation implementing additional tariffs on certain patented pharmaceutical products and ingredients. The order imposes a…
Headline
AHA makes recommendations to CMS on strengthening domestic supply chain for PPE, essential medicines
The AHA today submitted comments to the Centers for Medicare & Medicaid Services on an advanced notice of proposed rulemaking on potential options to…
Headline
ASPR to expand domestic production of ingredients for anesthesia, cardiovascular medications
The Administration for Strategic Preparedness and Response March 24 announced an investment to expand the domestic manufacturing of propofol and metoprolol.…
Headline
ASPR to invest in domestic production of ingredient for pain management, overdose reversal medications
The Administration for Strategic Preparedness and Response announced March 5 that it will invest in the domestic production of thebaine, an ingredient…
Headline
Supreme Court strikes down tariffs imposed under IEEPA
The Supreme Court Feb. 20 ruled that the International Emergency Economic Powers Act does not authorize the imposition of global tariffs. The court held that…